Weiping Zhou

19.8k citations
222 papers · 12.9k · 6 hit papers · h-index 51

Impact in

  • Cancer Research top 0.05%
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • RNA modifications and cancer 24
    • RNA Research and Splicing 11
    • Cancer-related gene regulation 8
    • Hepatocellular Carcinoma Treatment and Prognosis 56

Weiping Zhou

218 papers receiving 12.8k citations

Weiping Zhou's Hit Papers

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma 2018 · 577 citations
5770+5+10Years since publication4008001.2k

Peers

Weiping Zhou
Comparison fields: 5 of 158
  • Cancer Research 6.6k
  • Hepatology 1.3k
  • Molecular Biology 7.6k
  • Oncology 1.0k
  • Epidemiology 1.1k
Replace Haitao Zhao with:
Haitao Zhao China
Yang� Yang China
Mengchao Wu China
Antonio Russo Italy
Matthias Evert Germany
Thomas Longerich Germany
Gamze Karaca United States
Zhiqiang Meng China
Hirohisa Yano Japan
Beicheng Sun China
Weiping Zhou relative to Haitao Zhao China Haitao Zhao's profile →
Citations per field
00.5×5.3×
Haitao Zhao · 1×
Citations per year

Countries citing papers authored by Weiping Zhou

Since Specialization
Citations

This map shows the geographic impact of Weiping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Zhou more than expected).

Fields of papers citing papers by Weiping Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Zhou. The network helps show where Weiping Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Weiping Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiping Zhou Line = papers co-authored together Weiping Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
Hit paper breakdown →
20141284
2
Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression
Hit paper breakdown →
2017952
3
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processing
Hit paper breakdown →
2016693
4
Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
Hit paper breakdown →
2011605
5
Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
Hit paper breakdown →
2018577
6
Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans
Hit paper breakdown →
2011564
7 2013423
8 2015336
9 2012334
10 2012296
11 2012284
12 2017253
13 2014237
14 2010220
15 2011205
16 2008198
17 2010187
18 2005175
19 2009157
20 2010141

About Weiping Zhou

Weiping Zhou is a scholar working on Molecular Biology, Hepatology, Cancer Research, Surgery and Oncology, having authored 222 papers that have together received 12.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (56 papers), RNA modifications and cancer (24 papers), Cancer-related molecular mechanisms research (23 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), RNA Research and Splicing (11 papers), MicroRNA in disease regulation (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Cancer Research (6.6k citations), Hepatology (1.3k citations), Molecular Biology (7.6k citations), Oncology (1.0k citations) and Epidemiology (1.1k citations). Weiping Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fu Yang, Shuhan Sun, Yuan Yang, Shengxian Yuan, Ji‐hang Yuan, Jinzhao Ma, Qingguo Xu, Chuanchuan Zhou, Xisong Huo and Qi-fei Tao. Their work appears in journals such as Hepatology, Oncotarget, Journal of Hepatology, Frontiers in Oncology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact